日报更新时间：
周报更新时间：04-11 03:39
今开价：30.37
最高价：30.5
成交量：4092469.0
昨收价：30.2
最低价：29.52
最新价：29.98
英文名称：Elanco Animal Health Inc
简介：Elanco Animal Health Incorporated于2018年5月3日在印第安纳州注册成立
电话：1-877-3526261
自1954年礼来制药设立动物保健部以来，礼来动保始终致力于帮助兽医、食品生产商以及关注动物健康的人们应对全球挑战，实现让食品和伴侣动物不断丰富我们生活的愿景。通过创新，为客户、动物和环境开发安全产品，实现丰富人类生活的共同愿景。自1953年开发首例兽用抗生素到今天提供宠物健康解决方案，礼来动保始终秉承着严谨的科学理念，生产优质的产品，并与客户保持紧密关系。 面对全球未来挑战，礼来动保深感责任重大。因此，礼来动保将继续保持优良传统和价值观，为动物保健提供更多解决方案。
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| LAURION CAPITAL MANAGEMENT LP | 6546239 | 1.79% | 6221239 | 1914.23% | 2019-03-31 |
| Morgan Stanley - Brokerage Accounts | 10985451 | 3.00% | 2017328 | 22.49% | 2019-03-31 |
| Massachusetts Financial Services Company | 17618326 | 4.82% | 16225977 | 1165.37% | 2019-03-31 |
| MFS Investment Management KK | 17618326 | 4.82% | 16225977 | 1165.37% | 2019-03-31 |
| BlackRock Inc | 19559113 | 5.35% | 16835410 | 618.11% | 2019-03-31 |
| Wellington Management Company LLP | 24304234 | 6.65% | 20363544 | 516.75% | 2019-03-31 |
| Vanguard Group Inc | 28986515 | 7.93% | 22735630 | 363.72% | 2019-03-31 |
| PRIMECAP Management Company | 30607906 | 8.37% | 25645707 | 516.82% | 2019-03-31 |
| T. Rowe Price Associates, Inc. | 38678903 | 10.58% | 35844944 | 1264.84% | 2019-03-31 |
| Amundi Pioneer Asset Management, Inc. | 10657690 | 2.91% | 4890712 | 84.81% | 2019-03-31 |
| Lazard Asset Management LLC | 10641174 | 2.91% | 10641174 | -- | 2019-03-31 |
| Morgan Stanley Investment Management, Inc. | 9956827 | 2.72% | 1083030 | 12.20% | 2019-03-31 |
| T. Rowe Price | 6927906 | 1.89% | -553751 | -7.40% | 2019-07-31 |
| Morgan Stanley Investment Management Ltd | 6991655 | 1.91% | -1848 | -0.03% | 2019-07-31 |
| Citadel Advisors Llc | 7832197 | 2.14% | 7832197 | -- | 2019-03-31 |
| Invesco Ltd (OFI / OppenheimerFunds) | 7857990 | 2.15% | -10390 | -0.13% | 2019-07-31 |
| HHG PLC | 8278745 | 2.26% | 6546483 | 377.92% | 2019-03-31 |
| American Century Companies Inc | 8875571 | 2.43% | 6797761 | 327.16% | 2019-03-31 |
| OppenheimerFunds Inc | 9668160 | 2.64% | 9668160 | -- | 2019-03-31 |
| Vanguard Investments Australia Ltd | 9824808 | 2.69% | 635941 | 6.92% | 2019-07-31 |
| Janus Capital Management LLC | 7201967 | 1.97% | 5251897 | 269.32% | 2019-06-30 |
| State Street Corporation | 5910424 | 1.62% | 4727150 | 399.50% | 2019-03-31 |
| Waddell & Reed Investment Management Co | 6197630 | 1.69% | 3198738 | 106.66% | 2019-03-31 |
| Waddell & Reed Financial Inc | 6197630 | 1.69% | 3198738 | 106.66% | 2019-03-31 |
| Goldman Sachs Group Inc | 6484627 | 1.77% | 5314274 | 454.07% | 2019-03-31 |
| BlackRock Fund Advisors | 4434818 | 1.21% | -8782 | -0.20% | 2019-04-30 |
| Fidelity Management & Research Company | 4609225 | 1.26% | 1647443 | 55.62% | 2019-04-30 |
| Vanguard | 5218919 | 1.43% | 4916488 | 1625.66% | 2019-04-30 |
| OFI Global Asset Management, Inc. | 7868380 | 2.15% | 2238420 | 39.76% | 2019-04-30 |
| FMR Inc | 4415172 | 1.21% | 1131504 | 34.46% | 2018-12-31 |
| Fidelity Management and Research Company | 4377872 | 1.20% | 1094204 | 33.32% | 2018-12-31 |
| Capital Research and Management Company | 4073900 | 1.11% | -17868 | -0.44% | 2019-04-30 |
| American Century Investment Management, Inc | 3577074 | 0.98% | 2254704 | 170.50% | 2019-04-30 |
| Jackson National Asset Management LLC | 3094465 | 0.85% | 2753065 | 806.40% | 2019-04-30 |
| Franklin Advisers, Inc. | 3014972 | 0.82% | 1296731 | 75.47% | 2018-12-31 |
| Franklin Resources Inc | 3016932 | 0.82% | 1297131 | 75.42% | 2018-12-31 |
| Capital World Investors | 2435358 | 0.67% | -- | -- | 2018-12-31 |
| Wells Fargo & Co | 2896910 | 0.79% | 631015 | 27.85% | 2018-12-31 |
| Dodge & Cox | 2012033 | 0.55% | 2012033 | -- | 2018-09-30 |
| Kayne Anderson Rudnick Investment Management LLC | 1676118 | 0.46% | 1676118 | -- | 2018-09-30 |
| Wells Fargo Funds Management LLC | 1637143 | 0.45% | -61200 | -3.60% | 2019-01-31 |
| Columbia Mgmt Investment Advisers, LLC | 1553168 | 0.42% | 1553168 | -- | 2018-09-30 |
| Ameriprise Financial Inc | 1635300 | 0.45% | 1635300 | -- | 2018-09-30 |
| Federated Equity Mgmt Co. Of Penn | 1452750 | 0.40% | 1452750 | -- | 2018-11-30 |
| Wells Capital Management Inc. | 1573481 | 0.43% | 1573481 | -- | 2018-09-30 |
| JPMorgan Chase & Co | 1099435 | 0.30% | 1099435 | -- | 2018-09-30 |
| Invesco Advisers, Inc. | 893085 | 0.24% | 893085 | -- | 2018-11-30 |
| AllianceBernstein L.P. | 400908 | 0.11% | 400908 | -- | 2018-10-31 |
| BlackRock Advisors LLC | 539178 | 0.15% | 539178 | -- | 2018-10-31 |
| J.P. Morgan Investment Management, Inc. | 570800 | 0.16% | 570800 | -- | 2018-10-31 |
| Goldman Sachs Asset Management, L.P. | 799893 | 0.22% | 799893 | -- | 2018-10-31 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Vanguard Value Index Fund | 2324668 | 0.64% | 145359 | 6.67% | 2019-06-30 |
| Pioneer Fd | 5159561 | 1.41% | -- | -- | 2019-06-30 |
| Invesco Oppenheimer Main Strt fd | 6003770 | 1.64% | -- | -- | 2019-06-30 |
| MS INVF US Advantage Fund | 6154441 | 1.68% | 168482 | 2.81% | 2019-03-31 |
| T. Rowe Price Mid-Cap Growth Fund | 8000000 | 2.19% | 500000 | 6.67% | 2019-06-30 |
| Vanguard Mid-Cap Index Fund | 8207616 | 2.24% | 1005384 | 13.96% | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 9716242 | 2.66% | 636018 | 7.00% | 2019-06-30 |
| Vanguard Health Care Fund | 10448499 | 2.86% | 9398707 | 895.29% | 2019-03-31 |
| Vanguard PrimeCap Fund | 13864940 | 3.79% | 13536940 | 4127.12% | 2019-03-31 |
| Vanguard Extended Market Index Fund | 5028371 | 1.37% | -29315 | -0.58% | 2019-06-30 |
| T. Rowe Price Value Fund | 4534553 | 1.24% | 402800 | 9.75% | 2019-06-30 |
| Vanguard PrimeCap Core Fund | 4473412 | 1.22% | 1845212 | 70.21% | 2019-03-31 |
| Old Westbury Large Cap Strategies Fund | 2375000 | 0.65% | 2375000 | -- | 2019-04-30 |
| Vanguard Windsor | 2540265 | 0.69% | 2540265 | -- | 2019-03-31 |
| PrimeCap Odyssey Growth Fund | 2904144 | 0.79% | 11374 | 0.39% | 2019-06-30 |
| UBS: Global Equity-UBS | 3071238 | 0.84% | 3071238 | -- | 2019-03-31 |
| Vanguard Mid-Cap Value Index Fund | 3283800 | 0.90% | 315503 | 10.63% | 2019-06-30 |
| Vanguard Capital Opportunity Fund | 3438438 | 0.94% | 3160438 | 1136.85% | 2019-03-31 |
| MFS Massachusetts Investors Gr Stk Fund | 3580376 | 0.98% | -- | -- | 2019-06-30 |
| T. Rowe Price Mid-Cap Value Fund | 3723904 | 1.02% | -- | -- | 2019-06-30 |
| T. Rowe Price Lg-Cap Core Gr Strat-UBS | 3199132 | 0.87% | 3199132 | -- | 2019-03-31 |
| T. Rowe Price Blue Chip Growth Fund | 3199132 | 0.87% | 3199132 | -- | 2019-03-31 |
| American Funds IS | 2291100 | 0.63% | 692490 | 43.32% | 2019-03-31 |
| Oppenheimer Main Street Fund | 6003770 | 1.64% | 2000020 | 49.95% | 2019-03-31 |
| Pioneer Fundamental Growth Fund | 1953262 | 0.53% | 1847143 | 1740.63% | 2019-03-31 |
| Ivy Core Equity Fund | 2096883 | 0.57% | 393548 | 23.10% | 2019-03-31 |
| T. Rowe Price Health Sciences Fund | 2162600 | 0.59% | 1683191 | 351.10% | 2019-03-31 |
| BlackRock Health Sciences Opps Port | 1802360 | 0.49% | 1355300 | 303.16% | 2019-02-28 |
| CTIVP Morgan Stanley Advantage Fund | 1678859 | 0.46% | -- | -- | 2019-02-28 |
| State Street Russell Small/Mid Cap | 1439584 | 0.39% | 1117200 | 346.54% | 2019-03-31 |
| Franklin DynaTech Fund | 1200000 | 0.33% | -- | -- | 2019-02-28 |
| MFS Research Fund | 1175922 | 0.32% | 370366 | 45.98% | 2019-02-28 |
| Wells Fargo Discovery Fund | 1099718 | 0.30% | 532700 | 93.95% | 2019-02-28 |
| Hartford Capital Appreciation Fund | 1082561 | 0.30% | 376331 | 53.29% | 2019-02-28 |
| Oppenheimer Main Street Mid Cap Fund | 1081380 | 0.30% | 1081380 | -- | 2019-02-28 |
| Fidelity | 1070500 | 0.29% | -- | -- | 2019-01-31 |
| Franklin DynaTech | 1200000 | 0.33% | -- | -- | 2019-02-28 |
| Janus Henderson Enterprise Fund | 782587 | 0.21% | -- | -- | 2018-12-31 |
| MFS Mid Cap Growth Fund | 844217 | 0.23% | 46663 | 5.85% | 2019-01-31 |
| American Century Heritage Fund | 980219 | 0.27% | 403534 | 69.97% | 2018-12-31 |
| AZ InvestEd Ivy Core Equity Fund | 1703335 | 0.47% | 1463338 | 609.73% | 2018-12-31 |
| Dodge & Cox Stock Fund | 1280733 | 0.35% | 1280733 | -- | 2018-09-30 |
| Federated Kaufmann Fund | 935650 | 0.26% | 935650 | -- | 2018-09-30 |
| Franklin Growth Fd | 610307 | 0.17% | -- | -- | 2018-11-30 |
| Franklin Growth Fund | 610307 | 0.17% | -- | -- | 2018-11-30 |
| Interfund Equity USA Advantage | 505650 | 0.14% | -- | -- | 2018-11-30 |
| MFS | 741192 | 0.20% | 611271 | 470.49% | 2018-10-31 |
| Federated Kaufmann Large Cap Fd | 491200 | 0.13% | 491200 | -- | 2018-09-30 |
| Goldman Sachs Small/Mid Cap Growth Fund | 415902 | 0.11% | 415902 | -- | 2018-09-30 |
| Art A. Garcia | Art A. Garcia is on the board of ABM Industries, Inc. and Elanco Animal Health, Inc. In the past Mr. Garcia was Chief Financial officer & Executive Vic President at Ryder System, Inc., Chief Financial Officer of Blue Dot Services, Inc. and Senior Manager-Business Assurance at Coopers & Lybrand LLP. Mr. Garcia received an undergraduate degree from Florida State University. |
|---|---|
| John P. Bilbrey | John P. Bilbrey is a businessperson who has been at the helm of 5 different companies. He is on the board of Campbell Soup Co., Colgate-Palmolive Co., Elanco Animal Health, Inc. and Folium Biosciences LLC and Owner at Bilbrey Farm & Ranch LLC. In the past John P. Bilbrey was Non-Executive Chairman for The Hershey Co. and President & Senior Vice President at Hershey's International, Inc. (a subsidiary of The Hershey Co.), Category Manager at Procter & Gamble Co., President & Chief Executive Officer at Danone Waters of North America, Inc., Chief Executive Officer of Del Monte Foods Co., Executive Vice President-Sales at Mission Foods Corp. and Chairman for Grocery Manufacturers Association. He received an undergraduate degree from Kansas State University. |
| Lawrence Erik Kurzius | Lawrence Erik Kurzius is Chairman, President & Chief Executive Officer of McCormick & Co., Inc. Mr. Kurzius is also on the board of 8 other companies. In the past he was Principal at Mars, Inc., Principal at Uncle Bens, Inc., President & Chief Executive Officer at Zatarain's Brands, Inc. and Principal at The Quaker Oats Co. Mr. Kurzius received an undergraduate degree from Princeton University. |
| Deborah Turner Kochevar | Deborah Turner Kochevar is on the board of Charles River Laboratories International, Inc. and Elanco Animal Health, Inc. and Senior Vice President for Tufts University. In the past Dr. Kochevar held the position of President for Association of American Veterinary Medical College, Chairman-Education Council at American Veterinary Medical Association, Member of College of Veterinary Medicine & Biomedical Sciences, President-Veterinary Clinical Pharmacology at The American College and Dean at Cummings School of Veterinary Medicine. She received a doctorate from The American College, an undergraduate degree from Rice University, a doctorate from Texas A&M University and a doctorate from The University of Texas Southwestern Medical Center. |
| R. David Hoover | R. David Hoover occupies the position of Independent Chairman for Elanco Animal Health, Inc. He is also Member of The Colorado Forum and on the board of 6 other companies. In his past career he occupied the position of Chairman at Ball Corp. and Vice Chairman & Chief Financial Officer at Ball Aerospace & Technologies Corp. (a subsidiary of Ball Corp.), Member of Can Manufacturers Institute, Inc. and Member-Deans Council at Kelley School of Business. Mr. Hoover received an undergraduate degree from DePauw University and an MBA from Indiana University. |
| James T. Morris | James T. Morris is on the board of Old National Bank (Evansville, Indiana), Hulman & Co., Church World Service, Inc. and Indianapolis Motor Speedway LLC and Director-Strategic Policy Board at Elanco Animal Health, Inc. In the past Mr. Morris occupied the position of Vice Chairman of Pacers Basketball LLC, Chief of Staff-Mayors Office at City & County of Indianapolis-Marion County (Indiana), Chairman & Chief Executive Officer of Indianapolis Water Co. LLC, Chairman, President & Chief Executive Officer of IWC Resources Corp. and President of Lilly Endowment, Inc. He received an undergraduate degree from Indiana University and an MBA from Butler University. |
| Kapila Kapur Anand | Kapila Kapur Anand is on the board of Omega Healthcare Investors, Inc. and 6 other companies. In her past career she held the position of Chairman of The Chicago Network, Industry Segment Leader-Travel & Leisure at KPMG LLP and Chairman of KPMG Foundation. Ms. Anand received an MBA and an undergraduate degree from Michigan State University. |
| Denise Vera Pollard-Knight | Dr. Denise V. Pollard-Knight is Managing Partner at Phase4 Ventures Ltd. She is on the Board of Directors at Mereo BioPharma Group Plc, OncoMed Pharmaceuticals, Inc., Albireo Ltd., Albireo Pharma, Inc., British Heart Foundation and Albireo AB. Dr. Pollard-Knight was previously employed as Managing Partner by Phase4 Partners Ltd., Chairman-Supervisory Board by Nabriva Therapeutics AG, an Independent Director by Idenix Pharmaceuticals, Inc., Head-Healthcare Private Equity by Nomura International Plc, and a Member by Rothschild Asset Management Ltd. She also served on the board at Albireo Pharma, Inc., Cerimon Pharmaceuticals, Inc., DeveloGen AG and ViaCell, Inc. She received his undergraduate degree from the University of California, Berkeley, an undergraduate degree from the University of Birmingham and a doctorate degree from the University of Birmingham. |
| Jeffrey N. Simmons | Jeffrey N. Simmons is a businessperson who has been at the head of 5 different companies. He occupies the position of President, Chief Executive Officer & Director at Elanco Animal Health, Inc. He is also Chairman for International Federation for Animal Health. In his past career he was Senior Vice President of Eli Lilly & Co. and Country Director at Elanco Quimica Ltda (a subsidiary of Eli Lilly & Co.), President for Elanco US, Inc., Chairman at The National FFA Organization, President at Health For Animals and Director at Animal Health Institute. Mr. Simmons received an undergraduate degree from Cornell University. |
| Kirk P. McDonald | Founder of Venture Industries, Inc., Kirk P. McDonald is a businessperson who has been the head of 6 different companies and presently is Chairman at Code and Chief Marketing Officer for Xandros, Inc. He is also Co-Chairman for Mouse, Inc. (New York) and Chairman at Camp Interactive and on the board of 5 other companies. In the past he held the position of Chairman of VGTel, Inc. and Chairman for Venture Industries, Inc. (a subsidiary of VGTel, Inc.), President for PubMatic, Inc., Advisor at Luma Partners LLC, President-Digital at TI Gotham, Inc., Senior Vice President-Network Sales at CNET, Inc. (Texas), Senior Vice President at CBS Interactive, Inc., SVP-Sales, Marketing & Client Services at Atlas Solutions, Inc. (Washington), Senior Vice President-Sales for Atlas Group, Inc., Manager-District Sales at Ziff Davis, Inc. and SVP-Sales, Marketing & Client Services at DRIVE Performance Media. Mr. McDonald received an undergraduate degree from City University of New York. |
| Roy Riggs | Roy Riggs is Director-Dairy Business Unit at Elanco Animal House, Inc. |
| Joshua L. Smiley | Presently, Joshua L. Smiley holds the position of Chief Financial Officer & Senior Vice President of Eli Lilly & Co. and Treasurer, Director & Vice President at CoLucid Pharmaceuticals, Inc. (a subsidiary of Eli Lilly & Co.). Mr. Smiley is also on the board of Butler University, Eskenazi Health Foundation and Elanco Animal Health, Inc. He previously held the position of Chief Financial Officer, Controller & SVP-Finance at Lilly Research Laboratories. He received an undergraduate degree from Harvard University. |
| David A. Ricks | David A. Ricks is on the board of Adobe, Inc., The Central Indiana Corporate Partnership, James Whitcomb Riley Children's Foundation and Elanco Animal Health, Inc. and Chairman, President & Chief Executive Officer for Eli Lilly & Co. and Treasurer & Director at Pharmaceutical Research & Manufacturers of America. Mr. Ricks previously occupied the position of Principal at International Business Machines Corp., Principal at HP, Inc., President at Lilly USA LLC, President & General Manager at Lilly Industries Shanghai Ltd., General Manager for Eli Lilly Canada, Inc. and President at International Federation of Pharmaceutical Manufacturers. David A. Ricks received an MBA from Indiana University and an undergraduate degree from Purdue University. |
| Sarena S. Lin | Sarena S. Lin is on the board of Indiana Chamber of Commerce, Greater Twin Cities United Way, Animal Health Institute and Perspectives, Inc. and EVP-Corporate Strategy & Global Marketing at Elanco Animal Health, Inc. Ms. Lin previously held the position of President-Feed & Nutrition at Cargill, Inc., Managing Partner-McKinsey Asia Center at McKinsey & Co., Inc., Principal at Procter & Gamble Co., Senior VP-North American Operations & Strategy at Eli Lilly & Co. and Chairman for Cargill AS (Norway). Ms. Lin received a graduate degree from Yale University, an undergraduate degree from Harvard University and an MBA from Yale School of Management. |
| Michael J. Harrington | Michael J. Harrington is Co-Chairman of Civil Justice Reform Group and Senior Vice President & General Counsel for Eli Lilly & Co. and on the board of 6 other companies. In his past career he occupied the position of Managing Director at Eli Lilly & Company (N.Z.) Ltd. and Principal at Baker & Daniels LLP. Michael J. Harrington received an undergraduate degree from Albion College and a graduate degree from Columbia Law School. |
| Robin S. Readnour | Currently, Robin S. Readnour holds the position of Managing Director at Mountain Group Capital LLC. He is also on the board of Biotechnology Innovation Organization and Applied Lifesciences & Systems Poultry, Inc. and Senior Director-Product Development at Elanco Animal Health, Inc. Dr. Readnour received a doctorate from the University of Illinois. |
| Robin S. Readnour | Currently, Robin S. Readnour holds the position of Managing Director at Mountain Group Capital LLC. He is also on the board of Biotechnology Innovation Organization and Applied Lifesciences & Systems Poultry, Inc. and Senior Director-Product Development at Elanco Animal Health, Inc. Dr. Readnour received a doctorate from the University of Illinois. |
| Todd S. Young | Currently, Todd S. Young holds the position of Chief Financial Officer & Executive Vice President at Elanco Animal Health, Inc. In the past Mr. Young held the position of Executive VP, Chief Financial & Accounting Officer at ACADIA Pharmaceuticals, Inc., Treasurer & Vice President of Baxter International, Inc., Tax Attorney at Sidley & Austin and Senior Vice President at Baxalta, Inc. Todd S. Young received an undergraduate degree from Grinnell College and a graduate degree from The University of Michigan Law School. |
| Michael-Bryant Hicks | Presently, Michael-Bryant Hicks is Secretary, Executive VP & General Counsel of Elanco Animal Health, Inc. In the past he occupied the position of Assistant General Counsel at DaVita, Inc., Secretary, Chief Compliance Officer & Senior VP at Providence Service Corp., General Counsel at Mallinckrodt Pharmaceuticals, Senior Vice President & General Counsel of Mallinckrodt Plc and Associate General Counsel & Head-Legal Support at Beckman Coulter, Inc. Mr. Hicks received a graduate degree from Yale Law School and an undergraduate degree from the University of North Carolina at Chapel Hill. |
| Aarti Shah | Dr. Aarti Shah is a Chief Information Officer & SVP-IT at Eli Lilly & Co. She is on the Board of Directors at Center of Interfaith Corp., Indianapolis Public Library Foundation and Shrimad Rajchandra Love & Care. Dr. Shah also served on the board at Elanco Animal Health, Inc. She received her undergraduate degree from the University of California, Riverside, a graduate degree from the University of California, Riverside and a doctorate degree from the University of California, Riverside. |
| Aaron L. Schacht | Presently, Aaron L. Schacht is EVP-Innovation, Regulatory & Business Development at Elanco Animal Health, Inc. Mr. Schacht is also on the board of AgTech Accelerator Corp. He previously occupied the position of Executive Director-Global External R&D at Eli Lilly & Co. and Vice President-Global Research & Development at Eli Lilly & Co. He received an undergraduate degree from the University of Illinois. |
| Lucas E. Montarce | Lucas E. Montarce is on the board of Christel House International, Inc. and Vice President of Elanco Animal Health, Inc. In the past he occupied the position of Treasury Director, CFO-Latin America, Europe & US at Eli Lilly & Co. Mr. Montarce received an undergraduate degree from The Catholic University of America and an MBA from Universidad del CEMA. |
| David S. Kinard | David S. Kinard occupies the position of Executive Vice President-Human Resources at Elanco Animal Health, Inc. Mr. Kinard is also on the board of Conner Prairie Museum, Inc. In his past career he was Accounts Manager at Walker Information, Inc., Vice President-Human Resources of Eli Lilly & Co. Head-Global Employee Relations at Lilly USA LLC and Vice President-Human Resources of Lilly Diabetes (both are subsidiaries of Eli Lilly & Co.) and Production Manager at Honeywell International LLC. David S. Kinard received an undergraduate degree and a graduate degree from Brigham Young University. |
| Ramiro Cabral | Currently, Ramiro Cabral occupies the position of Chief Marketing Officer & VP-Marketing at Elanco Animal House, Inc. |
| Genefer Douglass | Presently, Genefer Douglass holds the position of Senior Director-Ethics & Compliance at Elanco Animal Health, Inc. She received an undergraduate degree and a graduate degree from the University of Illinois. |
| Carl L. McMillian | Carl L. McMillian is on the board of Elanco Animal Health, Inc. and International Consortium for Innovation & Quality and VP-Toxicology, Drug Disposition & PKPD at Eli Lilly & Co. Mr. McMillian received an undergraduate degree and a graduate degree from Auburn University. |
| Lawrence Erik Kurzius | Lawrence Erik Kurzius is Chairman, President & Chief Executive Officer of McCormick & Co., Inc. Mr. Kurzius is also on the board of 8 other companies. In the past he was Principal at Mars, Inc., Principal at Uncle Bens, Inc., President & Chief Executive Officer at Zatarain's Brands, Inc. and Principal at The Quaker Oats Co. Mr. Kurzius received an undergraduate degree from Princeton University. |
| Kirk P. McDonald | Founder of Venture Industries, Inc., Kirk P. McDonald is a businessperson who has been the head of 6 different companies and presently is Chairman at Code and Chief Marketing Officer for Xandros, Inc. He is also Co-Chairman for Mouse, Inc. (New York) and Chairman at Camp Interactive and on the board of 5 other companies. In the past he held the position of Chairman of VGTel, Inc. and Chairman for Venture Industries, Inc. (a subsidiary of VGTel, Inc.), President for PubMatic, Inc., Advisor at Luma Partners LLC, President-Digital at TI Gotham, Inc., Senior Vice President-Network Sales at CNET, Inc. (Texas), Senior Vice President at CBS Interactive, Inc., SVP-Sales, Marketing & Client Services at Atlas Solutions, Inc. (Washington), Senior Vice President-Sales for Atlas Group, Inc., Manager-District Sales at Ziff Davis, Inc. and SVP-Sales, Marketing & Client Services at DRIVE Performance Media. Mr. McDonald received an undergraduate degree from City University of New York. |
| David Urbanek | David Urbanek is Executive Vice President-Manufacturing & Quality at Elanco Animal Health, Inc. |
| James M. Meer | Presently, James M. Meer occupies the position of Chief Accounting Officer at Elanco Animal Health, Inc. In the past Mr. Meer held the position of Chief Financial Officer of Healthx, Inc., Senior Vice President-Finance of Appirio, Inc. and Vice President & Corporate Controller at ExactTarget LLC. |
| Christopher Keeley | Currently, Christopher Keeley occupies the position of Chief Information Officer & Vice President at Elanco Animal Health, Inc. In the past Mr. Keeley held the position of VP-Information Technology Products & Engineering at Bayer CropScience LP. Mr. Keeley received an undergraduate degree from Bowdoin College and a graduate degree from Columbia University. |
| Rhonda Hoffman | Currently, Rhonda Hoffman occupies the position of Chief Marketing Officer & Vice President at Elanco Animal Health, Inc. In the past Ms. Hoffman held the position of President of Olentangy Athletic Boosters and President at Vrios Agency. Ms. Hoffman received an MBA from The Ohio State University. |
| Fadi Debes | Presently, Fadi Debes holds the position of Vice President & Corporate Controller at Elanco Animal Health, Inc. In the past Mr. Debes occupied the position of Senior Director-Research Laboratories at Eli Lilly & Co. He received an undergraduate degree from Saint Joseph University (Beirut) and a graduate degree from �0�1‰cole des Hautes �0�1‰tudes Commerciales de Paris. |
| Julie Lawless | Presently, Julie Lawless is Vice President-Corporate Affairs & Administration at Elanco Animal Health, Inc. Ms. Lawless is also on the board of Pet Partners and Chairman of Health For Animals. Ms. Lawless received an undergraduate degree from the University of Missouri-St. Louis. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论